198 related articles for article (PubMed ID: 20487670)
41. Lactose filler as a cause of "drug-induced" diarrhea.
Lieb J; Kazienko DJ
N Engl J Med; 1978 Aug; 299(6):314. PubMed ID: 661937
[No Abstract] [Full Text] [Related]
42. Compounding with Silicones.
Allen LV
Int J Pharm Compd; 2015; 19(3):223-30. PubMed ID: 26714363
[TBL] [Abstract][Full Text] [Related]
43. [Pharmacopeia and preparations for cutaneous application].
Esnault F; Etchegaray JP; Mallard C
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
[No Abstract] [Full Text] [Related]
44. Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review.
Zakhem GA; Motosko CC; Mu EW; Ho RS
J Am Acad Dermatol; 2019 Apr; 80(4):957-969. PubMed ID: 30287313
[TBL] [Abstract][Full Text] [Related]
45. [Pharmaceutical drugs containing lactose can as a rule be used by persons with lactose intolerance].
Vinther S; Rumessen JJ; Christensen M
Ugeskr Laeger; 2015 Mar; 177(11):. PubMed ID: 25786702
[TBL] [Abstract][Full Text] [Related]
46. Medicines containing pharmaceutical excipients with known effects: a French review.
Fusier I; Tollier C; Husson MC
Pharm World Sci; 2003 Aug; 25(4):152-5. PubMed ID: 12964493
[TBL] [Abstract][Full Text] [Related]
47. Adverse effects of pharmaceutical excipients in drug therapy.
Wong YL
Ann Acad Med Singap; 1993 Jan; 22(1):99-102. PubMed ID: 8503648
[TBL] [Abstract][Full Text] [Related]
48. Sodium hydroxymethylglycinate.
Russell K; Jacob SE
Dermatitis; 2010; 21(2):109-10. PubMed ID: 20233550
[TBL] [Abstract][Full Text] [Related]
49. Tartrazine: a potentially hazardous dye in Canadian drugs.
MacCara ME
Can Med Assoc J; 1982 Apr; 126(8):910-4. PubMed ID: 7074487
[TBL] [Abstract][Full Text] [Related]
50. Place of excipients in systemic drug allergy.
Barbaud A
Immunol Allergy Clin North Am; 2014 Aug; 34(3):671-9, x. PubMed ID: 25017684
[TBL] [Abstract][Full Text] [Related]
51. Review of parenteral sulfite reactions.
Smolinske SC
J Toxicol Clin Toxicol; 1992; 30(4):597-606. PubMed ID: 1433430
[TBL] [Abstract][Full Text] [Related]
52. Fixed food eruption caused by lactose identified after oral administration of four unrelated drugs.
Tsuruta D; Sowa J; Kobayashi H; Ishii M
J Am Acad Dermatol; 2005 Feb; 52(2):370-1. PubMed ID: 15692494
[No Abstract] [Full Text] [Related]
53. Skin healing preparations: compared in vitro diffusion of the active ingredients.
Vennat B; Arvouet-Grand A; Pourrat A
Drug Dev Ind Pharm; 1998 Mar; 24(3):253-60. PubMed ID: 9876582
[TBL] [Abstract][Full Text] [Related]
54. Choosing a medication brand: Excipients, food intolerance and prescribing in older people.
Page A; Etherton-Beer C
Maturitas; 2018 Jan; 107():103-109. PubMed ID: 29169573
[TBL] [Abstract][Full Text] [Related]
55. Stability of Organoleptic Agents in Pharmaceuticals and Cosmetics.
Patil A; Bhide S; Bookwala M; Soneta B; Shankar V; Almotairy A; Almutairi M; Narasimha Murthy S
AAPS PharmSciTech; 2018 Jan; 19(1):36-47. PubMed ID: 28900868
[TBL] [Abstract][Full Text] [Related]
56. [Composition of topical drugs].
Zerrouk N; Arnaud P
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S27-9. PubMed ID: 17563711
[No Abstract] [Full Text] [Related]
57. Basics: Excipients Used in Nonsterile Compounding, Part 2.
Allen LV
Int J Pharm Compd; 2019; 23(5):393-396. PubMed ID: 31513538
[TBL] [Abstract][Full Text] [Related]
58. Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations.
Thomazini VC; da Cunha GM; Guimarães NM; Saleme SD; de Melo RCG; de Paula GA; Carvalho SG; Chorilli M; Dos Santos Giuberti C; Villanova JCO
Daru; 2024 Jun; 32(1):289-305. PubMed ID: 37903944
[TBL] [Abstract][Full Text] [Related]
59. The quality of skin care products and their ingredients.
Zatz JL
Ostomy Wound Manage; 2001 Feb; 47(2):22-33. PubMed ID: 11235497
[TBL] [Abstract][Full Text] [Related]
60. Oleamidopropyl dimethylamine.
de Groot AC
Derm Beruf Umwelt; 1989; 37(3):101-5. PubMed ID: 2743873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
